Newsletter

Subscribe and recieve updates on this company.

Text STOCKS to 72727 for mobile alerts

We are excited to present NanoVibronix, Inc. (NASDAQ: NAOV).

Full DD Report for NAOV

You must become a subscriber to view this report.


Recent News from (NASDAQ: NAOV)

NanoVibronix reports Q2 results
NanoVibronix (NASDAQ: NAOV ): Q2 EPS of -$0.13 More news on: NanoVibronix, Inc., Earnings news and commentary, Healthcare stocks news, , Read more ...
Source: SeekingAlpha
Date: August, 16 2018 08:09
NanoVibronix Provides Business Update for the Second Quarter of 2018
Revenue increases 153% for the second quarter of 2018 ELMSFORD, N.Y., Aug. 16, 2018 (GLOBE NEWSWIRE) -- NanoVibronix, Inc, (NASDAQ: NAOV), a medical device company utilizing the Company's proprietary and patented low intensity surface acoustic wave (SAW) technology, today provided a...
Source: GlobeNewswire
Date: August, 16 2018 08:00
NanoVibronix Reports Successful Trial Results for Use of PainShield(TM) in Patients with Trigeminal Neuralgia; Reinforces Potential as Alternative to Opioids and Surgical Interventions
ELMSFORD, N.Y., July 24, 2018 (GLOBE NEWSWIRE) -- NanoVibronix, Inc, (NASDAQ:NAOV), a medical device company utilizing the Company's proprietary and patented low intensity surface acoustic wave (SAW) technology, today announced successful results for its PainShield™ device in treat...
Source: GlobeNewswire
Date: July, 24 2018 07:30
NanoVibronix announces exclusive agreement for distribution of Painshield and Woundshield in Israel
NanoVibronix (NASDAQ: NAOV ) has entered into an exclusive agreement with M.D.S. Pharm Ltd. to market and distribute NanoVibronix’s PainShield and WoundShield in Israel. More news on: NanoVibronix, Inc., Healthcare stocks news, Stocks on the move, Read more ...
Source: SeekingAlpha
Date: June, 05 2018 07:56
NanoVibronix Announces Exclusive Agreement for Distribution of PainShield® and WoundShield® in Israel
ELMSFORD, N.Y., June 05, 2018 (GLOBE NEWSWIRE) -- NanoVibronix, Inc., (NASDAQ:NAOV), a medical device company utilizing the Company’s proprietary and patented low intensity surface acoustic wave (SAW) technology, today announced it has entered into an exclusive agreement with M.D.S...
Source: GlobeNewswire
Date: June, 05 2018 07:00
NanoVibronix to Present at the 8th Annual LD Micro Invitational Conference
ELMSFORD, NY / ACCESSWIRE / June 1, 2018 / NanoVibronix, Inc, (NASDAQ: NAOV), a medical device company utilizing the Company's proprietary and patented low intensity surface acoustic wave (SAW) technology, today announced that it will be presenting at the 8th Annual LD Micro Invitational Con...
Source: ACCESSWIRE
Date: June, 01 2018 07:30
NanoVibronix reports Q1 results
NanoVibronix (NASDAQ: NAOV ): Q1 EPS of -$0.12. More news on: NanoVibronix, Inc., Earnings news and commentary, Healthcare stocks news, , Read more ...
Source: SeekingAlpha
Date: May, 17 2018 09:57
NanoVibronix Provides Business Update for the First Quarter 2018
ELMSFORD, N.Y., May 17, 2018 (GLOBE NEWSWIRE) -- NanoVibronix, Inc, (NASDAQ:NAOV) , a medical device company utilizing the Company's proprietary and patented low intensity surface acoustic wave (SAW) technology, today provided a business update for the first quarter of 2018. Brian Mur...
Source: GlobeNewswire
Date: May, 17 2018 09:44
NanoVibronix Partners with Fabrication Enterprises, Inc. for Distribution of PainShield® in the United States
ELMSFORD, N.Y., May 09, 2018 (GLOBE NEWSWIRE) -- NanoVibronix, Inc., (NASDAQ:NAOV) , a medical device company utilizing the Company’s proprietary and patented low intensity surface acoustic wave (SAW) technology, today announced it has partnered with Fabrication Enterprises, Inc. ...
Source: GlobeNewswire
Date: May, 09 2018 07:00
NanoVibronix to Present at the 3rd Annual Disruptive Growth & Healthcare Conference Hosted by RHK Capital and Reed Smith
NEW YORK, May 01, 2018 (GLOBE NEWSWIRE) -- NanoVibronix, Inc., (NASDAQ:NAOV), a medical device company utilizing the Company’s proprietary and patented low intensity surface acoustic wave (SAW) technology, today announced that it will be presenting at the 3 rd annual Disruptive Gr...
Source: GlobeNewswire
Date: May, 01 2018 08:39

 


Last 5 Days Trading Activity

DateOpen PriceClose PriceHighLowVolume
2018-09-084.524.674.724.3917,182
2018-05-184.534.604.704.538,244
2018-05-174.534.604.704.538,244

Last 5 Days Short Activity

DateShort VolumeTotal VolumeShort PercentageShort Indicator
2018-12-0311100.0000Short
2018-11-3010010397.0874Short
2018-11-2933100.0000Short
2018-11-2140060066.6667Short
2018-11-157001,60043.7500Short

* Short Mode

Short Analysis provided by Squeeze Report. Get a complete short report on NAOV.


About NanoVibronix, Inc. (NASDAQ: NAOV)

Logo for NanoVibronix, Inc. (NASDAQ: NAOV)

NanoVibronix develops innovative medical devices based on its proprietary therapeutic ultrasound technology. Our products address a range of clinical applications including catheter related injury and its complications, pain and soft tissue healing.

 

 

 

Current Management

  • Brian S. Murphy / CEO
  • Stephen R Brown / CFO
  • Christopher M. Fashek / Chairman, Independent Director
  • Michael Ferguson / Independent Director
  • Martin Goldstein / Independent Director
  • Harold Jacob /
  • Thomas R. Mika / Independent Director
  • Jona Zumeris /

Current Share Structure

  • Market Cap: $18,104,979 - 03/12/2018
  • Authorized: 24,000,000 - 03/01/2018
  • Issue and Outstanding: 3,935,865 - 03/01/2018
  • Float: 2,632,710 - 08/15/2016

 


Recent Filings from (NASDAQ: NAOV)

Quarterly report with a continuing view of a company's financial position
Filing Type: 10-QFiling Source: edgar
Filing Date: May, 15 2018
Additional proxy soliciting materials - definitive
Filing Type: DEFA14AFiling Source: edgar
Filing Date: May, 08 2018
Additional proxy soliciting materials - definitive
Filing Type: DEFA14AFiling Source: edgar
Filing Date: May, 08 2018
Additional proxy soliciting materials - definitive
Filing Type: DEFA14AFiling Source: edgar
Filing Date: May, 04 2018
Additional proxy soliciting materials - definitive
Filing Type: DEFA14AFiling Source: edgar
Filing Date: May, 04 2018
Additional proxy soliciting materials - definitive
Filing Type: DEFA14AFiling Source: edgar
Filing Date: May, 03 2018
Report of unscheduled material events or corporate changes.
Filing Type: 8-KFiling Source: edgar
Filing Date: May, 03 2018
Additional proxy soliciting materials - definitive
Filing Type: DEFA14AFiling Source: edgar
Filing Date: May, 03 2018
Report of unscheduled material events or corporate changes.
Filing Type: 8-KFiling Source: edgar
Filing Date: May, 03 2018
Official notification to shareholders of matters to be brought to a vote (Proxy)
Filing Type: DEF 14AFiling Source: edgar
Filing Date: April, 30 2018

 

 


Daily Technical Chart for (NASDAQ: NAOV)

Daily Technical Chart for (NASDAQ: NAOV)


Stay tuned for daily updates and more on (NASDAQ: NAOV)

It most certainly could but even more important is the recent overwhelming interest in the company. Check out Investors Hub and search on Twitter

More to come on (NASDAQ: NAOV)

Do your DD and if you choose, be ready to go!


 

The Research: All source information contained in this email is from the public sources mentioned below.

 

 
 

Thank you

DD Report
@DDReports

 

 


Disclaimer: DD Report publishes reports providing information on selected companies. DD Report is not a registered investment advisor or broker-dealer. This report is provided as an information service only, and the statements and opinions in this report should not be construed as an offer or solicitation to buy or sell any security. DD Report accepts no liability for any loss arising from an investors reliance on or use of this report. An investment in NAOV is considered to be highly speculative and should not be considered unless a person can afford a complete loss of investment. DD Report has received no compensation for the publication and circulation of this report. DD Report does not own any shares of NAOV and does not buy, sell, or trade any shares of NAOV. This report contains forward-looking statements, which involve risks, and uncertainties that may cause actual results to differ materially from those set forth in the forward-looking statements. Copyright 2018 by DD Report. All rights reserved. Our Full Disclaimer: https://dd.report/disclaimer/